Polypharmacy, High-Risk Drug Classes, and Adverse Health Outcomes With T1D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Association of Polypharmacy and High-Risk Drug Classes With Adverse Health Outcomes in the Scottish Population With Type 1 Diabetes
Diabetologia 2021 Jun 01;64(6)1309-1319, A Höhn, A Jeyam, TM Caparrotta, SJ McGurnaghan, JE O'Reilly, LAK Blackbourn, RJ McCrimmon, GP Leese, JA McKnight, B Kennon, RS Lindsay, N Sattar, SH Wild, PM McKeigue, HM Colhoun, Scottish Diabetes Research Network (SDRN) Epidemiology GroupFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.